In This Section
WATCH NOW!! FDA ADVOCATE LISTENING SESSION ON CANCER CLINICAL TRIALS DURING COVID-19
WATCH NOW!! FDA ADVOCATE LISTENING SESSION ON CANCER CLINICAL TRIALS DURING COVID-19

The American Association for Cancer Research (AACR) and the U.S. Food and Drug Administration (FDA) recorded a listening session on May 27, 2020 for patient advocates to learn more about cancer clinical trials during COVID-19 and the recently issued COVID-19 Related Guidance Documents for Industry, FDA Staff, and Other Stakeholders.

Tell Us: How have you been affected by the coronavirus?
PATIENT ADVOCACY RESOURCES TO COMBAT COVID-19
PATIENT ADVOCACY RESOURCES TO COMBAT COVID-19

Nonprofit patient advocacy leaders have created a number of resources to help patients with cancer navigate their treatment and care during the COVID-19 pandemic. To help and inform our community, we are sharing these resources in one central list. We will be updating this list regularly.

Cancer Survivor and Patient Advocacy Program

Building upon the AACR’s longstanding commitment to foster partnerships with cancer survivors and patient advocates—and to fulfill its goal of significantly expanding these relationships—the association established the Cancer Survivor and Patient Advocacy Program in  2004.

Our Mission

The AACR’s Cancer Survivor and Patient Advocacy Program is dedicated to fostering mutually beneficial and enduring partnerships among leaders of the cancer survivor, patient advocacy, and scientific communities.

By strengthening communications and developing collaborations among these key constituencies, the program enhances efforts to accelerate progress against cancer. To advance the prevention and cure of the disease, it is critical that advocates and scientists work together to increase funding for cancer research, further participation in clinical trials, improve clinical trial design, and facilitate access to cancer information for the general public. The Cancer Survivor and Patient Advocacy Program strengthens and supports these synergistic collaborations.

Opportunities for patient advocates

Cancer survivors and patient advocates provide valuable insight throughout the research continuum to inform scientific discovery, public policy, and clinical research. To encourage participation in research, AACR offers patient advocates and cancer survivors a number of resources, tools, and opportunities, such as:

Scientist↔Survivor Program®

Learn More
Addressing Advocacy at the Bench

Learn More
Advocates on Capitol Hill

Learn More

Advocacy alerts

Join our email list to get news and updates about AACR’s Patient Advocacy Programs.

Sign up

Learn More: